111 related articles for article (PubMed ID: 10935223)
1. A comparative study of MIB-1 staining indices of gliomas measured by NIH Image analysis program and conventional manual cell counting method.
Amin MR; Kurosaki M; Watanabe T; Tanaka S; Hori T
Neurol Res; 2000 Jul; 22(5):495-500. PubMed ID: 10935223
[TBL] [Abstract][Full Text] [Related]
2. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell counting using an image analysis program for MIB-1 immunohistochemistry.
Ide M; Jimbo M; Yamamoto M; Kubo O
Neurol Med Chir (Tokyo); 1997 Feb; 37(2):158-62. PubMed ID: 9059038
[TBL] [Abstract][Full Text] [Related]
5. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
6. Comparison of manual and digital microvascular density counting of RECK expression in glioma.
Rahmah NN; Sakai K; Li Y; Sano K; Hongo K
Neuropathology; 2012 Jun; 32(3):245-51. PubMed ID: 22098593
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
[TBL] [Abstract][Full Text] [Related]
9. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study.
Rodríguez-Pereira C; Suárez-Peñaranda JM; Vázquez-Salvado M; Sobrido MJ; Abraldes M; Barros F; Forteza J
J Neurosurg Sci; 2000 Dec; 44(4):203-9; discussion 209-10. PubMed ID: 11327289
[TBL] [Abstract][Full Text] [Related]
10. The correlation between 99mTc-MIBI uptake and MIB-1 as a nuclear proliferation marker in glioma--a comparative study with 201Tl.
Nagamachi S; Jinnouchi S; Nabeshima K; Nishii R; Flores L; Kodama T; Kawai K; Tamura S; Yokogami K; Samejima T; Wakisaka S
Neuroradiology; 2001 Dec; 43(12):1023-30. PubMed ID: 11792039
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas.
Struikmans H; Rutgers DH; Jansen GH; Dullens HF; Oosten L; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1999; 7(4):243-8. PubMed ID: 10492165
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system.
Ren Y; Munyer P; Kepes JJ; Cansler M; Collins J; Gayed B; Tawfik O
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):14-8. PubMed ID: 11277408
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
14. Ki-67/MIB-1 immunostaining in a cohort of human gliomas.
Skjulsvik AJ; Mørk JN; Torp MO; Torp SH
Int J Clin Exp Pathol; 2014; 7(12):8905-10. PubMed ID: 25674263
[TBL] [Abstract][Full Text] [Related]
15. Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study.
Kros JM; Schouten WC; Janssen PJ; van der Kwast TH
Acta Neuropathol; 1996; 91(1):99-103. PubMed ID: 8773153
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
McKeever PE; Ross DA; Strawderman MS; Brunberg JA; Greenberg HS; Junck L
J Neuropathol Exp Neurol; 1997 Jul; 56(7):798-805. PubMed ID: 9210876
[TBL] [Abstract][Full Text] [Related]
17. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.
Hsu DW; Louis DN; Efird JT; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1997 Aug; 56(8):857-65. PubMed ID: 9258255
[TBL] [Abstract][Full Text] [Related]
18. Nuclear-labeling index analysis (NLIA), a software package used to perform accurate automation of cell nuclear-labeling index analysis on immunohistochemically stained rat liver samples.
Xu YH; Sattler GL; Edwards H; Pitot HC
Comput Methods Programs Biomed; 2000 Aug; 63(1):55-70. PubMed ID: 10927155
[TBL] [Abstract][Full Text] [Related]
19. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.
Hsu CY; Ho DM; Yang CF; Chiang H
Mod Pathol; 2003 Sep; 16(9):951-7. PubMed ID: 13679460
[TBL] [Abstract][Full Text] [Related]
20. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas.
von Bossanyi P; Sallaba J; Dietzmann K; Warich-Kirches M; Kirches E
Pathol Res Pract; 1998; 194(3):141-7. PubMed ID: 9587931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
